Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

IPSEN PORTUGAL - PRODUTOS FARMACEUTICOS S.A.

NIF 502609800
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €16,267,780 67 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €16,267,780 67 contracts
A2 · Late Publication €5,322,914,855 1,435 contracts
Contract published to BASE more than 10 days after the signing date
LOW €5,322,914,855 1,435 contracts
A5 · Threshold Splitting €2,953,810 62 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €2,953,810 62 contracts
A6 · Low Competition €2,660,248 27 contracts
Only one bidder participated in a competitive procedure
MEDIUM €2,660,248 27 contracts
A9 · Abnormal Price Reduction €6,550,001,606 614 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €6,550,001,606 614 contracts
C3 · Missing Mandatory Fields €3,398,167 50 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €3,398,167 50 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

210
€519,225,237
55
€326,327,827
97
€293,023,862
31
€284,443,340
19
€270,557,693
77
€266,963,845
25
€260,016,401
86
€253,474,890
140
€250,219,002
94
€247,412,555
24
€242,087,789
19
€221,963,916
9
€218,182,967
35
€217,334,268
214
€214,411,343
64
€210,591,444
10
€206,821,443
19
€202,938,635
15
€196,820,942
17
€183,522,067
Page 1 of 3 · 52 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 2 · 62 contracts

RELAXANTES MUSCULARES AÇÃO CENTRAL - TOXINA BOTULÍNICA
PT · 13324516 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€142,613 2026-02-12
AE/2795/2025 - CABOZANTINIB (80MG+20MG) CP
PT · 12712938 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€73,200 2025-11-07
MEDICAMENTOS
PT · 11869468 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,073 2025-10-28
ADCM3064/25 - MEDICAMENTOS DIVERSOS
PT · 11616235 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€149,723 2025-07-11
Aquisição de Anti-Psicóticos, Anestésicos e Relaxantes Musculares - AQ2022/19 SPMS
PT · 11639587 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€148,515 2025-05-08
Medicamentos
PT · 11371302 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€72,968 2025-04-17
31/634/205 - Medicamento Lanreotida 120 mg/488 mg Sol inj Ser 0.5 ml SC
PT · 11295704 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€144,416 2025-01-21
VÁRIOS MEDICAMENTOS
PT · 11191927 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,862 2025-01-20
LANREOTIDA 120 MG/488 MG SOL INJ SER 0.5 ML SC
PT · 10944314 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,982 2024-09-23
Aquisição de Foslevodopa 240 mg/ml + Foscarbidopa 12 mg/ml Sol inj Fr 10 ml SC e Cabozantinib 60mg ao abrigo do Acordo Quadro 2023/671
PT · 10933160 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€144,991 2024-06-20
LANREOTIDA [120 MG/488 MG; SERINGA], POR REAÇÃO ADVERSA
PT · 10779569 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,121 2024-06-14
Q1/682/2024 - MEDICAMENTOS DIVERSOS
PT · 10596196 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€73,383 2024-03-04
090100192023 - LANREOTIDA SOL INJ SER 0,5 ML SC
PT · 9945295 · Consulta Prévia
A5 · Threshold Splitting A2 · Late Publication
€73,353 2023-02-24
MEDICAMENTOS DIVERSOS 2021/55
PT · 9944686 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€143,573 2023-01-03
221000563/13559 - VÁRIOS MEDICAMENTOS
PT · 9537378 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,152 2022-11-05
Aquisição de Somatropina 10mg/2ml sol inj cart SC (Nutropin)
PT · 10211137 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +1
€19,200 2022-06-30
Medicamentos Relaxantes Musculares_SPMS_Bianual_2022_2023
PT · 9262005 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€142,857 2022-04-28
LANREOTIDA 120MG SOL. INJ. SERINGA
PT · 9185366 · Ajuste Direto Regime G...
A5 · Threshold Splitting
€19,121 2022-04-07
2022003187 - FAR HOSP - Lanreotida 120 mg Sol Inj Ser 0,5 ml SC
PT · 9610840 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,780 2022-03-09
AQUISIÇÃO DE MEDICAMENTOS DIVERSOS - 55/2019
PT · 9105339 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€149,833 2022-02-09
LANREOTIDA 120MG SOL INJ SERINGA
PT · 8255337 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2021-08-16
Medicamentos Diversos
PT · 7703517 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,271 2021-06-11
2021005854 - Triptorrelina 22.5 mg Pó susp inj Fr IM
PT · 7763783 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,937 2021-05-27
CP2021020029 - LANREOTIDA
PT · 8132685 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2021-02-10
BEAD20200478 - LANREOTIDA
PT · 7451100 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2020-12-22
BEAD20200437 - HORMONA LIBERTADORA -GONADOTROPINA 1 MÊS
PT · 7500007 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,749 2020-10-15
AQUISIÇÃO DE MEDICAMENTOS DIVERSOS - CPA 2017/6
PT · 6980715 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€74,974 2020-09-22
BEAD20200384 - HORMONA LIBERTADORA GONADOTROPINA
PT · 7452775 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,749 2020-09-04
LANREOTIDA 120 MG / 488 MG SOL INJ SER 0.5 ML SC
PT · 7064532 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2020-07-30
Lanreotida 120mg/488mg
PT · 6567116 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€71,704 2020-03-30
Lanreotida 120 mg
PT · 6464588 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2020-02-14
Lanreotida 120 mg/488 mg Sol inj Ser 0.5 ml SC
PT · 6511599 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2020-01-03
Lanreotida 120 mg/488 mg Sol inj Ser 0.5 ml SC
PT · 6507689 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2020-01-02
31/3693/2019- Lanreotida 120 mg/488 mg
PT · 6187710 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2019-12-11
HORMONA LIBERTADORA GONADOTROPINA
PT · 6049509 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,749 2019-11-21
HORMONA LIBERTADORA GONADOTROPINA - 1º SEMESTRE
PT · 5611343 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,749 2019-06-04
31/414/2019 - Medicamento "Lanreotida LP"
PT · 8724512 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,909 2019-02-05
4180070/2019 - P259-2018-170 LANREOTIDA 120 MG e TRIPTORELINA 11.25 MG e 3.75 MG
PT · 5821331 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€73,126 2019-01-16
4180070/2019 - P259-2018-170 LANREOTIDA 120 MG e TRIPTORELINA 11.25 MG e 3.75 MG
PT · 5821354 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€73,126 2019-01-16
4180070/2019 - P259-2018-170 LANREOTIDA 120 MG e TRIPTORELINA 11.25 MG e 3.75 MG
PT · 5821339 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€73,126 2019-01-16
HORMONA LIBERTADORA GONADOTROPINA 2018
PT · 4942659 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,749 2018-11-02
MEDICAMENTOS
PT · 4918893 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,704 2018-10-25
FI0458/2018 - LANREÓTIDA 120 MG
PT · 5521653 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,780 2018-09-14
FI0434/2018 - LANREÓTIDA 120 MG SERINGA PRÉ CHEIA SOL INJ 0,5 ML
PT · 5502584 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,780 2018-08-10
Aquisição medicamentos exclusivos - Lanreotida
PT · 4515255 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2018-03-23
P259-AC-2017-146_AQUISIÇÃO DE MEDICAMENTOS DESENCADEADA PELA SPMS, EPE NO ÂMBITO DO DESPACHO 1571/B DE 2016 AO ABRIGO DO ACORDO QUADRO 2015/007 - Hormonas e outros medicamentos usados no tratamento das doenças endócrinas
PT · 4098190 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€74,369 2018-01-01
FI0577/2017 - LANREÓTIDA 120 MG SERINGA PRÉ CHEIA SOL INJ 0,5 ML - L44 - CIRCULAR 8)
PT · 4260012 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,780 2017-09-01
FI0353/2017 - LANREOTIDA 120MG, TRIPTORELINA 11,25 MG P259-AC-2017-40
PT · 4371471 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,121 2017-04-04
HIPOTALAMO E HIPOFISE
PT · 3168010 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,283 2017-03-06
AD2715-16LANREOTIDA 120 MG INJ LM
PT · 2571825 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,706 2016-10-19
Next →
Overview
Total Value Won
€6,626,637,573
Contracts Won
1,973
Score 70600 · CRITICAL RISK
NIF
502609800
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.A. [P-f417]
    Vogal
    since 2023-01-04
  • A.C. [P-19a3]
    Presidente
    since 2019-11-05
  • A.C. [P-19a3]
    Presidente
    since 2023-01-04
  • C.F. [P-aacf]
    Vogal
    since 2015-03-05
  • E.H. [P-639f]
    Vogal
    since 2014-04-02
  • E.H. [P-639f]
    Vogal
    since 2015-03-05
  • G.G. [P-d47a]
    Presidente
    since 2026-03-26
  • G.W. [P-488a]
    Presidente
    since 2014-12-04
  • J.P. [P-30d5]
    Vogal
    since 2016-05-16
  • L.P. [P-e470]
    Vogal
    since 2020-12-19
  • L.P. [P-e470]
    Vogal
    since 2023-01-04
  • L.G. [P-9eca]
    Vogal
    since 2016-05-16
  • M.C. [P-186f]
    Vogal
    since 2025-05-19
  • P.M. [P-62b5]
    Vogal
    since 2009-05-06
  • R.G. [P-95e5]
    Vogal
    since 2026-03-26
  • C.J. [P-e2b7]
    Fiscal Único
    since 2023-01-04
  • C.J. [P-e2b7]
    Fiscal Único
    since 2025-05-19
  • C.L. [P-db3e]
    Fiscal Único
    since 2018-06-21
  • D.A. [P-c2b1]
    Fiscal Único
    since 2018-06-21
  • J.E. [P-a0dd]
    Fiscal Único
    since 2016-12-14
  • J.G. [P-0a73]
    Fiscal Único
    since 2009-05-06
  • J.G. [P-0a73]
    Fiscal Único
    since 2015-03-05
  • K.A. [P-e283]
    Fiscal Único
    since 2009-05-06
  • K.A. [P-e283]
    Fiscal Único
    since 2015-03-05
  • P.A. [P-4562]
    Fiscal Único
    since 2023-01-04
  • P.A. [P-4562]
    Fiscal Único
    since 2025-05-19
  • A.A. [P-f417]
    Vogal
    2025-05-19 → 2026-03-26
  • A.E. [P-f7c9]
    Vogal
    2019-05-28 → 2022-10-03
  • A.C. [P-19a3]
    Presidente
    2025-05-19 → 2026-03-26
  • A.M. [P-e4bd]
    Presidente
    2009-05-06 → 2014-12-04
  • C.F. [P-aacf]
    Vogal
    2012-11-22 → 2016-04-08
  • F.G. [P-310d]
    Vogal
    2009-05-06 → 2012-11-16
  • G.W. [P-488a]
    Vogal
    2012-11-22 → 2014-04-02
  • G.W. [P-488a]
    Presidente
    2015-03-05 → 2015-09-28
  • J.P. [P-30d5]
    Vogal
    2018-06-21 → 2019-03-27
  • L.G. [P-9eca]
    Presidente
    2018-06-21 → 2019-11-05
  • M.C. [P-d530]
    Vogal
    2019-11-05 → 2020-12-09
  • P.M. [P-62b5]
    Vogal
    until 2012-11-16
  • S.D. [P-b05c]
    Vogal
    2018-06-21 → 2019-11-05
  • J.G. [P-0a73]
    Fiscal Único
    until 2016-12-14
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned